Log in
Show password
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 


SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Coronavirus: The United States Provides Additional $5 Million for Urgent Coronavirus Assistance in Egypt

10/14/2021 | 10:04am EST

The U.S. Government, through the U.S. Agency for International Development, is providing over $5 million in urgent Coronavirus assistance for Egypt in cooperation with the Ministry of International Cooperation and the Ministry of Health and Population. This assistance will support health workers administering vaccines and strengthen the supply chain of vaccines to ensure equitable access throughout Egypt. The funding will also strengthen the ability of Egypt's health system to prevent, detect, and respond to the Coronavirus and to future public health threats.

"This additional $5 million in Coronavirus support reaffirms the U.S. Government's commitment to support Egypt through the global health crisis," said U.S. Ambassador Jonathan R. Cohen. "The United States and Egypt have been working side-by-side to fight Coronavirus. At the outset of the pandemic, Egypt sent medical supplies to the United States. And last week, I was pleased to welcome the arrival of 1.6 million Pfizer vaccine doses."

"Committed to recovery, the Government of Egypt is utilizing international cooperation with bilateral and multilateral development partners to respond to the challenging repercussions posed by the pandemic. Egypt's cooperation with the United States has supported the country's national agenda, in line with the UN Sustainable Development Goals, namely in the health, education and gender sectors," said H.E. Dr. Rania A. Al-Mashat, the Minister of International Cooperation, commenting on the additional U.S. commitment of $5 million for urgent COVID-19 assistance.

"I'd like to thank the United States Government for their support and long-standing cooperation, especially during the COVID-19 pandemic. We appreciate international solidarity during this time of crisis. Last week, we graciously received the first shipment of Pfizer vaccine donations from the U.S. through COVAX, which will help Egyptians stay healthy during this difficult time. USAID and the Ministry of Health and Population have a long history of cooperation in the health sector, and I look forward to further cooperation in the years to come," said H.E. Dr. Hala Zayed, Minister of Health and Population.

The U.S. Government, through USAID, has now provided more than $55 million in Coronavirus assistance to Egypt since the pandemic began, already reaching nearly 18 million people with needed health and economic support. USAID programs train health care workers, improve tracking of and response to the pandemic, provide food assistance to families affected by the pandemic, and support small businesses. This support builds on more than $1 billion in U.S. government investment over the past 40 years to improve the health of all Egyptians.

Diseases know no borders. The United States is committed to partnering with Egypt to end the Coronavirus pandemic, mitigate its devastating social and economic impacts, and build a world prepared for future outbreaks.

Distributed by APO Group on behalf of U.S. Embassy - Cairo, Egypt.


(C) 2021 M2 COMMUNICATIONS, source M2 PressWIRE

All news about PFIZER, INC.
12/03FDA adds strict safety warnings on arthritis drugs from Pfizer, AbbVie and Lilly
12/03Health Care Ticks Lower As Pfizer Gains - Health Care Roundup
12/03PFIZER : FDA Issues Update to XELJANZ« Prescribing Information in the United States
12/03U.S. administers 466.3 mln doses of COVID-19 vaccines - CDC
12/03Merck to supply up to 1 mln courses of COVID-19 pill to Canada
12/03Canada Signs Deal for 1 Mln Doses of Pfizer Covid Antiviral and 500K Merck's Covid Pill
12/03Vaccine makers could make Omicron-specific booster, says Fauci
12/03BioNTech Capable of Quickly Modifying Vaccine for Omicron Variant, CEO Says
12/03BioNTech CEO Expects To Modify COVID-19 Vaccine To Omicron Variant
12/03Malaysia Confirms First Case of New COVID-19 Variant
More news
Analyst Recommendations on PFIZER, INC.
More recommendations
Financials (USD)
Sales 2021 81 517 M - -
Net income 2021 21 354 M - -
Net Debt 2021 27 873 M - -
P/E ratio 2021 14,0x
Yield 2021 2,91%
Capitalization 305 B 305 B -
EV / Sales 2021 4,08x
EV / Sales 2022 3,84x
Nbr of Employees 78 500
Free-Float 59,3%
Duration : Period :
Pfizer, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends PFIZER, INC.
Short TermMid-TermLong Term
Income Statement Evolution
Mean consensus OUTPERFORM
Number of Analysts 22
Last Close Price 54,27 $
Average target price 49,58 $
Spread / Average Target -8,65%
EPS Revisions
Managers and Directors
Albert Bourla Chairman, Chief Executive & Operating Officer
Susan Silbermann President & General Manager-Pfizer Vaccines
Frank A. D'Amelio Chief Financial Officer & EVP-Global Supply
Mikael Dolsten Chief Scientific Officer & Research President
Lidia L. Fonseca Executive VP, Chief Digital & Technology Officer
Sector and Competitors
1st jan.Capi. (M$)
PFIZER, INC.44.09%304 610
JOHNSON & JOHNSON1.27%419 583
ROCHE HOLDING AG17.62%341 364
NOVO NORDISK A/S64.51%244 010
ABBVIE INC.8.18%210 113